文献速递乳腺心血管乳腺X线

乳腺X线筛查超越乳腺癌:乳腺动脉钙化作为女性心血管风险的特异性生物标志物

Screening mammography beyond breast cancer: breast arterial calcifications as a sex-specific biomarker of cardiovascular risk.
PubMed 文献 · Eur J Radiol · 2019-08-11

该文总结乳腺动脉钙化(BAC)与心血管疾病风险的证据,指出年龄、产次、糖尿病和高脂血症与BAC正相关;有BAC的女性短暂性脑缺血发作/卒中相对风险1.4、血栓形成1.5、心肌梗死1.8,冠心病风险比1.32、心力衰竭1.52、心血管死亡1.29、冠心病死亡1.44;但BAC常仅被报告为「存在」,未影响心血管决策,BAC定量标准化困难,机器学习定量BAC显示有前景的结果。

要点

  • BAC与心血管疾病风险升高相关,但日常乳腺X线报告中常仅描述为「存在」,未用于心血管风险分层。
  • 有BAC女性心肌梗死相对风险1.8、冠心病风险比1.32、心血管死亡风险比1.29,均高于无BAC者。
  • BAC定量方法不统一:18项已发表研究中9项仅报告有无、4项用半定量量表、5项用连续量表。

核心结论

  • 有强烈理由使乳腺X线成为乳腺癌筛查和心血管疾病预防的双重检查,但需要稳健的自动定量方法以深入理解BAC与心血管疾病的关联、分层心血管风险和定义个性化预防措施。

研究设计与样本

  • 本文为对该主题现有证据的总结,未报告系统检索范围、纳入文献数量或证据分级方法。

关键影像表现/征象

  • BAC在乳腺X线上易于检出,与心血管疾病相关,被视为女性心血管疾病预防的潜在影像生物标志物。
  • 年龄、产次、糖尿病和高脂血症与BAC呈正相关。
  • BAC的表现多样、拓扑复杂及血管重叠使BAC定量难以标准化。
  • 机器学习方法在乳腺X线上BAC定量方面显示出有前景的结果。

诊断标准与关键数值

  • 有BAC女性相比无BAC女性:短暂性脑缺血发作/卒中相对风险1.4、血栓形成相对风险1.5、心肌梗死相对风险1.8。
  • 有BAC女性相比无BAC女性:冠心病风险比1.32、心力衰竭风险比1.52、心血管死亡风险比1.29、冠心病死亡风险比1.44。
  • 18项已发表研究中,9项仅报告BAC存在/不存在,4项使用半定量量表,5项使用连续量表(手动、自动或半自动分割)。

临床应用与阅片要点

  • BAC在乳腺X线上易于检出,可报告其存在,但当前放射科医生未将其作为警示信号,报告时通常仅提及「存在」,未影响心血管决策。
  • BAC定量因表现多样、拓扑复杂和血管重叠而难以标准化,机器学习方法在BAC定量方面显示出有前景的结果。

局限性

  • BAC的表现多样、拓扑复杂和血管重叠使BAC定量难以标准化。
  • 需要稳健的自动定量方法以深入理解BAC与心血管疾病的关联、分层心血管风险和定义个性化预防措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To highlight the importance of quantitative breast arterial calcifications (BAC) assessment for an effective stratification of cardiovascular (CV) risk in women, for whom current preventive strategies are inadequate. BAC, easily detectable on mammograms, are associated with CV disease and represent a potential imaging biomarker for CV disease prevention in women.

METHOD: We summarized the available evidence on this topic.

RESULTS: Age, parity, diabetes, and hyperlipidemia were found to positively correlate with BAC. Women with BAC have a higher CV risk than those without BAC: the relative risk was reported to be 1.4 for transient ischemic attack/stroke, 1.5 for thrombosis, 1.8 for myocardial infarction; the reported hazard ratio was 1.32 for coronary artery disease (CAD), 1.52 for heart failure, 1.29 for CV death, 1.44 for death from CAD. However, BAC do not alarm radiologists; when reported, they are commonly mentioned as "present", not impacting on CV decision-making. Of 18 published studies, 9 reported only presence/absence of BAC, 4 used a semi-quantitative scale, and 5 a continuous scale (with manual, automatic or semiautomatic segmentation). Various appearance, topological complexity, and vessels overlap make BAC quantification difficult to standardize. Nevertheless, machine learning approaches showed promising results in BAC quantification on mammograms.

CONCLUSIONS: There is a strong rationale for mammography to become a dual test for breast cancer screening and CV disease prevention. However, robust and automated quantification methods are needed for a deeper insight on the association between BAC and CV disease, to stratifying CV risk and define personalized preventive actions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Trimboli RM, Codari M, Guazzi M, et al. Screening mammography beyond breast cancer: breast arterial calcifications as a sex-specific biomarker of cardiovascular risk. Eur J Radiol. 2019. PMID: 31493727. doi:10.1016/j.ejrad.2019.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。